OBD — Oxford Biodynamics Cashflow Statement
0.000.00%
Last trade - 00:00- £10.08m
- £13.80m
- £1.10m
Annual cashflow statement for Oxford Biodynamics, fiscal year end - September 30th, GBP millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | 2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -7.63 | -7.57 | -11.4 | -12 | -11.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 0.245 | -0.778 | 1.62 | 0.513 | 1.24 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.378 | 1.96 | 0.143 | -0.195 | 1.41 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -5.92 | -5.18 | -8.29 | -10.2 | -7.57 |
| Capital Expenditures | -3.09 | -0.901 | -0.716 | -0.595 | -0.244 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 5.92 | 2.15 | 0.096 | -0.89 | 1.06 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 2.83 | 1.25 | -0.62 | -1.49 | 0.813 |
| Financing Cash Flow Items | — | -0.358 | -1.46 | -0.984 | -0.459 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.804 | 2.56 | 13.2 | 8.25 | 6.33 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -3.94 | -1.2 | 4.28 | -3.42 | -0.435 |